Latest Breaking News On - Implanting demineralized bone matrix subfascially vs subcutaneously - Page 1 : comparemela.com

R. Lor Randall, MD, FACS, emphasizes the overall potential for investigating the utility of engineered bone marrow in patients with osteosarcoma, which highlights the ongoing research that is being conducted at the University of California Davis Comprehensive Cancer Center.

United statesUniversity of california davisDepartment of orthopedic surgeryProceedings of the national academy sciencesUc davis comprehensive cancer centerChildren oncology groupTheproceedings of the national academy sciencesNational academyDavis comprehensive cancer centerDavid linn endowed chairOrthopedic surgeryOncology groupImplanting demineralized bone matrix subfascially vs subcutaneouslyPatients with osteosarcomaR lor randallUniversity of california davis comprehensive cancer center